Share on StockTwits

CombiMatrix (NASDAQ:CBMX) Insider Robert Weslie Tyson bought 7,500 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 27th. The stock was purchased at an average price of $2.04 per share, for a total transaction of $15,300.00. Following the completion of the acquisition, the insider now directly owns 7,500 shares in the company, valued at approximately $15,300. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

CombiMatrix (NASDAQ:CBMX) opened at 1.87 on Tuesday. CombiMatrix has a 1-year low of $1.81 and a 1-year high of $4.44. The stock’s 50-day moving average is $2.13 and its 200-day moving average is $2.48. The company’s market cap is $20.7 million.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.